Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
(NASDAQ: ABVX) Delayed: 118.96 -2.49 (2.05%)
Previous Close $121.45    52 Week High $ 
Open $120.74    52 Week Low $ 
Day High $121.97    P/E N/A 
Day Low $117.90    EPS $ 
Volume 903,818       

(NASDAQ: ABVX) Delayed: 118.96 -2.49 (2.05%)
Previous Close $121.45    52 Week High $ 
Open $120.74    52 Week Low $ 
Day High $121.97    P/E N/A 
Day Low $117.90    EPS $ 
Volume 903,818